Wsfs Capital Management, LLC Cognition Therapeutics Inc Transaction History
Wsfs Capital Management, LLC
- $1.83 Billion
- Q4 2024
A detailed history of Wsfs Capital Management, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Wsfs Capital Management, LLC holds 23,337 shares of CGTX stock, worth $14,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,337Holding current value
$14,935% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
49Shares Held
13MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$3.84 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.41 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$795,2340.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$393,2730.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$320,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $14.5M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...